April 8 (Reuters) - MacroGenics Inc MGNX.O:
FDA REMOVES PARTIAL CLINICAL HOLD ON MACROGENICS’ LINNET STUDY
MACROGENICS INC - NEW PARTICIPANTS TO BE ENROLLED UNDER REVISED PROTOCOL WITH ADDITIONAL RISK-MITIGATION MEASURES
MACROGENICS INC: WE REMAIN ON TRACK TO PROVIDE A MID-YEAR CLINICAL UPDATE ON PROGRAM
MACROGENICS INC - PLAN TO RESUME ENROLLMENT IN CLINICAL STUDY OF LORIGERLIMAB IN GYNECOLOGIC CANCERS